Camu-camu extract reduces liver fat in non-alcoholic fatty liver disease

A research team from Université Laval has shown the benefits of camu-camu on non-alcoholic fatty liver disease, which affects over seven million people in Canada. This exotic fruit reduces liver fat levels. 

Over 12 weeks, thirty participants took either camu-camu extract or a placebo at different times in this randomized clinical trial. Participants underwent magnetic resonance imaging (MRI) to determine fat levels in the liver. Scientists observed a 7.43% reduction in liver lipids when study participants took camu-camu extract. With the placebo, they noted an 8.42% increase in liver fat.

"That's a significant 15.85% difference," says André Marette, a professor in the Faculty of Medicine and researcher at the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ), who led the study. 

Polyphenols and the microbiota 

This effect stems from the polyphenols contained in camu-camu and their relationship with the intestinal microbiota. "The microbiota metabolizes the large polyphenol molecules that cannot be absorbed by the intestine, transforming them into smaller molecules that the body can assimilate to decrease liver fat," explains André Marette. 

His team has identified two potential mechanisms of action for these small polyphenols. "They could reduce lipogenesis, i.e., the formation of lipid droplets in the liver. They could also stimulate lipid degradation by oxidation. A combination of the two mechanisms probably explains the high efficacy of the extract, as we're playing on both sides of the coin," reports Professor Marette, who collaborated with scientists at the Institute of Nutrition and Functional Foods (INAF). 

However, the team noted a wide variability in response to camu-camu.

We hypothesize that the initial intestinal microbiota influences the response to polyphenols. If we find the factors involved, we may be able to modify the microbiota and increase the extract efficacy."

André Marette, professor in the Faculty of Medicine and researcher at the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval

Although camu-camu is an exotic fruit, the extract is readily available in capsule form. However, Professor Marette stresses the importance of checking the content of certain polyphenols, as not all commercial products are equivalent. 

Cranberries, which also contain a number of partially different polyphenols, could also have a protective effect. In the future, Professor Marette hopes to investigate whether combining camu-camu and cranberry could have a synergistic effect. 

The study was published in the journal Cell Reports Medicine. The other authors are Anne-Laure Agrinier, Arianne Morissette, Laurence Daoust, Théo Gignac, Julie Marois, Thibault V. Varin, Geneviève Pilon, Éric Larose, Claudia Gagnon, Yves Desjardins, Fernando F Anhê, Anne-Marie Carreau and Marie-Claude Vohl. 

Source:
Journal reference:

Agrinier, A-L., et al. (2024) Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial. Cell Reports Medicine. doi.org/10.1016/j.xcrm.2024.101682.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ADAMTS13 deficiency drives platelet accumulation in pyrrolizidine alkaloid-induced liver injury